The Clorox Company
) strong revenue generating capabilities, impressive quarterly
beats and an upbeat outlook facilitated it to record a new
52-week high for the 3rd time in April.
After attaining a 52-week high of $89.66 on Apr 16, shares of
this consumer products company further soared to touch a new high
of $90.10 on Friday, Apr 19. Shares eventually closed at $89.53,
rising 20.8% year to date. The company currently trades at a
forward P/E of 20.7x, almost at par with the peer group average.
Alongside, companies like
The Home Depot Inc.
Rite Aid Corp.
) crafted new 52-week highs of $74.28, $119.89 and $2.48,
respectively on Apr 19.
Clorox's diversified portfolio of brands positions it well to
generate above-average industry growth amid a challenging
environment. The company's rigorous research & development
process, marketing strategies, financial control, and operating
leverage further strengthen its brands and facilitate it to
generate long-term profitability, which is well evident from its
record of beating the quarterly earnings expectations.
If we look at the company earnings surprise history, Clorox has
surpassed the Zacks Consensus Estimate in the last 9 quarters. In
the last reported quarter, the company's earnings beat the Zacks
Consensus Estimate by 11.1%.
Going forward, Clorox expects to sustain its growth momentum
through market share gains and product innovation. The company
raised its sales growth forecast to 3%-5% for fiscal 2013 from
2%-4% projected earlier.
In fiscal 2013, the company expects operating income margin to
expand 25-50 basis points (bps) on the back of efficient cost
savings, price increases and flat commodity costs. Further,
Clorox raised its fiscal 2013 earnings guidance range to
$4.25-$4.35 per share from the previous range of $4.20-$4.35.
Currently, shares of Clorox hold a Zacks Rank #3 (Hold).
COLGATE PALMOLI (CL): Free Stock Analysis
CLOROX CO (CLX): Free Stock Analysis Report
HOME DEPOT (HD): Free Stock Analysis Report
RITE AID CORP (RAD): Free Stock Analysis
To read this article on Zacks.com click here.